| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dibromopropamidine isethionate 0.1% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dibromopropamidine isethionate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dibromopropamidine isethionate |
Is a |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dibromopropamidine isethionate 0.1% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dibrompropamidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dibrompropamidine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dibrompropamidine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing calamine and dibrompropamidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dibrompropamidine isetionate |
Is a |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dibrompropamidine and undecylenic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dibrompropamidine isetionate |
Is modification of (attribute) |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dibrompropamidine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dibrompropamidine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to dibrompropamidine |
Causative agent (attribute) |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only calamine and dibrompropamidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only dibrompropamidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dibrompropamidine and undecylenic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dibrompropamidine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only dibrompropamidine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]